KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Clover Health Investments (CLOV) Notes Payables (2020 - 2021)

Clover Health Investments' Notes Payables history spans 2 years, with the latest figure at $21.4 million for Q1 2021.

For Q1 2021, Notes Payables rose 7041.67% year-over-year to $21.4 million; the TTM value through Mar 2021 reached $21.4 million, up 7041.67%, while the annual FY2020 figure was $20.8 million, N/A changed from the prior year.
Notes Payables reached $21.4 million in Q1 2021 per CLOV's latest filing, up from $20.8 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $21.4 million in Q1 2021 to a low of $300000.0 in Q1 2020.